PURPOSE: The retinoic acid receptors are expressed from early stages of development in the diverse tissues that make up the vertebrate eye. Their loss has subtle effects on eye development. We adapted sensitive quantitative trait locus (QTL) mapping methods to assess consequences of inactivating alleles of the alpha and beta receptors, Rara and Rarb, on eye and retinal development. Rara is of particular interest because this gene is a candidate for Nnc1, a QTL that controls retinal ganglion cell proliferation. METHODS: We studied lines of mice in which expression of the a1 isoform of Rara or all isoforms of Rarb had been disrupted by gene targeting. We measured eye weight, lens weight, retinal area, and retinal ganglion cell number in each of six genotypes (Rara and Rarb -/-, +/-, +/+; 10-25 cases/genotype). RESULTS: Loss of either protein is associated with a small but significant loss of eye weight and retinal area. However, only the Rarb knockout has a significant effect on the ganglion cell population and the loss of both wildtype alleles leads to an 8,000 cell deficit. Surprisingly, loss of the Rara a1 isoform that is expressed in this cell population from early stages has no effect on number. Null alleles of both genes have little if any effect on lens growth. CONCLUSIONS: Despite its expression in embryonic retina, Rara is unlikely to be the Nnc1 QTL. In contrast, Rarb, a gene that maps to Chr 14 and which is not an Nnc1 candidate gene, has a significant effect on cell number and is therefore a QTL controlling this key population. This raises the intriguing possibility that normal allelic variants of Rarb modulate the ganglion cell population in other vertebrates, including humans.
PURPOSE: The retinoic acid receptors are expressed from early stages of development in the diverse tissues that make up the vertebrate eye. Their loss has subtle effects on eye development. We adapted sensitive quantitative trait locus (QTL) mapping methods to assess consequences of inactivating alleles of the alpha and beta receptors, Rara and Rarb, on eye and retinal development. Rara is of particular interest because this gene is a candidate for Nnc1, a QTL that controls retinal ganglion cell proliferation. METHODS: We studied lines of mice in which expression of the a1 isoform of Rara or all isoforms of Rarb had been disrupted by gene targeting. We measured eye weight, lens weight, retinal area, and retinal ganglion cell number in each of six genotypes (Rara and Rarb -/-, +/-, +/+; 10-25 cases/genotype). RESULTS: Loss of either protein is associated with a small but significant loss of eye weight and retinal area. However, only the Rarb knockout has a significant effect on the ganglion cell population and the loss of both wildtype alleles leads to an 8,000 cell deficit. Surprisingly, loss of the Rara a1 isoform that is expressed in this cell population from early stages has no effect on number. Null alleles of both genes have little if any effect on lens growth. CONCLUSIONS: Despite its expression in embryonic retina, Rara is unlikely to be the Nnc1 QTL. In contrast, Rarb, a gene that maps to Chr 14 and which is not an Nnc1 candidate gene, has a significant effect on cell number and is therefore a QTL controlling this key population. This raises the intriguing possibility that normal allelic variants of Rarb modulate the ganglion cell population in other vertebrates, including humans.
Authors: Han na Park; Seema B Jabbar; Christopher C Tan; Curran S Sidhu; Jane Abey; Fazila Aseem; Gregor Schmid; P Michael Iuvone; Machelle T Pardue Journal: Invest Ophthalmol Vis Sci Date: 2014-09-02 Impact factor: 4.799
Authors: David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones Journal: Invest Ophthalmol Vis Sci Date: 2019-02-28 Impact factor: 4.799
Authors: Myriam Srour; David Chitayat; Véronique Caron; Nicolas Chassaing; Pierre Bitoun; Lysanne Patry; Marie-Pierre Cordier; José-Mario Capo-Chichi; Christine Francannet; Patrick Calvas; Nicola Ragge; Sylvia Dobrzeniecka; Fadi F Hamdan; Guy A Rouleau; André Tremblay; Jacques L Michaud Journal: Am J Hum Genet Date: 2013-09-26 Impact factor: 11.025
Authors: Jeffrey Wisard; Micah A Chrenek; Charles Wright; Nupur Dalal; Machelle T Pardue; Jeffrey H Boatright; John M Nickerson Journal: J Neurosci Methods Date: 2010-01-11 Impact factor: 2.390
Authors: Eldon E Geisert; Lu Lu; Natalie E Freeman-Anderson; Justin P Templeton; Mohamed Nassr; Xusheng Wang; Weikuan Gu; Yan Jiao; Robert W Williams Journal: Mol Vis Date: 2009-08-31 Impact factor: 2.367
Authors: S Veerappan; M Schäche; K K Pertile; F M A Islam; C Y Chen; P Mitchell; M Dirani; P N Baird Journal: Mol Vis Date: 2009-07-17 Impact factor: 2.367